GVAG
NVO

Great Valley Advisor Group’s Novo Nordisk NVO Stock Holding History

Great Valley Advisor Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$779K Buy
16,244
+5,768
+55% +$248K 0.01% 598
2026
Q1 		$385K Sell
10,476
-1,535
-13% -$72.7K 0.01% 756
2025
Q4 		$612K Sell
12,011
-1,181
-9% -$60.4K 0.01% 579
2025
Q3 		$732K Sell
13,192
-5,201
-28% -$304K 0.01% 540
2025
Q2 		$1.27M Sell
18,393
-69,182
-79% -$4.71M 0.03% 415
2025
Q1 		$6.08M Sell
87,575
-2,522
-3% -$208K 0.13% 159
2024
Q4 		$7.75M Buy
90,097
+55,192
+158% +$5.97M 0.17% 129
2024
Q3 		$4.16M Sell
34,905
-1,951
-5% -$260K 0.1% 206
2024
Q2 		$5.26M Buy
36,856
+1,571
+4% +$208K 0.15% 151
2024
Q1 		$4.53M Buy
35,285
+8,493
+32% +$1.01M 0.14% 164
2023
Q4 		$2.77M Buy
26,792
+7,563
+39% +$748K 0.1% 195
2023
Q3 		$1.75M Buy
19,229
+11,847
+160% +$1.04M 0.07% 236
2023
Q2 		$597K Buy
7,382
+2,850
+63% +$233K 0.03% 406
2023
Q1 		$360K Buy
4,532
+154
+4% +$10.9K 0.02% 494
2022
Q4 		$296K Buy
4,378
+66
+2% +$3.87K 0.02% 547
2022
Q3 		$215K Buy
4,312
+6
+0.1% +$321 0.01% 616
2022
Q2 		$240K Buy
+4,306
New +$239K 0.01% 598
2019
Q2 		– Sell
-13,688
Closed -$358K – 338
2019
Q1 		$358K Buy
13,688
+230
+2% +$5.65K 0.11% 195
2018
Q4 		$310K Buy
+13,458
New +$299K 0.12% 160

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Great Valley Advisor Group's NVO Position: Q2 2026 in Review

Great Valley Advisor Group increased its Novo Nordisk (NVO) stake by 55% in Q2 2026, buying an estimated $248K and bringing the position to 16,244 shares worth $779K. The position accounts for 0.01% of the portfolio, ranked #598.

Great Valley Advisor Group first reported a position in NVO in Q4 2018 and has held it in 19 quarters since. The position peaked at $7.75M in Q4 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Great Valley Advisor Group held 16,244 shares of Novo Nordisk worth $779K as of Q2 2026.
  • Great Valley Advisor Group bought 5,768 Novo Nordisk shares in Q2 2026, an estimated $248K.
  • Novo Nordisk made up 0.01% of Great Valley Advisor Group's portfolio in Q2 2026, its #598 holding.
  • Great Valley Advisor Group first reported a position in Novo Nordisk in Q4 2018 and has held it in 19 quarters since.
  • Great Valley Advisor Group's Novo Nordisk position peaked at $7.75M in Q4 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Great Valley Advisor Group's 13F filing for Q2 2026, filed 10 Aug 2026.